Sandra Talbird, MSPH

Senior Director, Health Economics

MSPH
University of North Carolina, Chapel Hill, NC

BA, Bachelor of Business Administration (Finance)
University of Notre Dame, Notre Dame, IN

Sandra Talbird, MSPH, is the Senior Director of Health Economics at RTI-HS. Her experience at RTI-HS includes designing and programming advanced economic models, such as cost-effectiveness, cost-utility, cost-benefit, and budget-impact models, using Microsoft Excel and Visual Basic for Applications. She has also developed mathematical models including compartmental dynamic transmission models for infectious diseases and linear programs in various software packages. She has extensive experience in preparing submissions to health technology assessment bodies in a variety of countries.

Ms. Talbird's academic training is grounded in finance, economics, and public health. Her primary research focus has been in infectious disease and vaccines, including treatment and prevention strategies for HIV, hepatitis C, influenza, malaria, meningococcal disease, herpes zoster, pertussis, pneumococcal disease, respiratory syncytial virus, tetanus, and varicella. Other therapeutic areas include oncology, women's health (including uterine fibroids) and reproductive health, and rare disease.

Ms. Talbird is an active member of the International Society of Pharmacoeconomics and Outcomes Research. She regularly participates as abstract reviewer, participates in the Rare Disease Special Interest Group, and is a primary reviewer for the Economic Evaluation of Vaccines Task Force. Her research has been presented at various professional conferences and published in several peer-reviewed journals, including AIDS, HIV Medicine, Vaccine, American Journal of Preventative Medicine, American Journal of Health-System Pharmacy and Value in Health.